电休克疗法
重性抑郁障碍
萧条(经济学)
医学
抗抑郁药
评定量表
生活质量(医疗保健)
前瞻性队列研究
内科学
队列
认知
精神科
心理学
焦虑
发展心理学
护理部
经济
宏观经济学
作者
Keyan Han,Chao‐Ming Wang,Chong-Bo Du,Jun Qiao,Yongliang Wang,Li-Zhao Lv
出处
期刊:World journal of psychiatry
[Baishideng Publishing Group Co (World Journal of Psychiatry)]
日期:2023-11-17
卷期号:13 (11): 949-957
被引量:1
标识
DOI:10.5498/wjp.v13.i11.949
摘要
Traditional treatments for major depressive disorder (MDD), including medication and therapy, often fail and have undesirable side effects. Electroconvulsive therapy (ECT) uses electrical currents to induce brief seizures in the brain, resulting in rapid and potent antidepressant effects. However, owing to misconceptions and controversies, ECT is not as widely used as it could and often faces stigmatization.To evaluate the efficacy and safety of ECT compared to those of medication and/or therapy in patients with severe MDD.This prospective cohort study included 220 individuals with severe MDD who were divided into the ECT and non-ECT groups. The patients in the ECT group underwent bilateral ECT three times a wk until they either achieved remission or reached a maximum of 12 sessions. The non-ECT group received medication and/or therapy according to clinical guidelines for MDD. The primary outcome was the variation in the hamilton depression rating scale (HDRS) score from treatment/ECT initiation to week 12. In addition, patients' quality of life, cognitive abilities, and biomarkers were measured throughout the study.Although both groups showed significant improvements in their HDRS scores over time, the improvement was more pronounced in the ECT group than in the non-ECT group. Additionally, the ECT group exhibited a more substantial improvement in the quality of life and cognitive function than those of the non-ECT group. Compared with the non-ECT group, the ECT group exhibited evi-dently lower variations in the brain-derived neurotrophic factor (BDNF) and cytokine interleukin-6 (IL-6) levels. The side effects were generally mild and comparable between the two groups. ECT is safer and more potent than medication and/or therapy in mitigating depressive symptoms, enhancing well-being, and bolstering cognitive capabilities in individuals with severe MDD. ECT may also affect the levels of BDNF and IL-6, which are indicators of neuroplasticity and inflammation, respectively.ECT has emerged as a potentially advantageous therapeutic approach for patients with MDD who are unresponsive to alternative treatments.
科研通智能强力驱动
Strongly Powered by AbleSci AI